Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...

The rising global incidence of Type 1 diabetes mellitus (T1DM) calls for innovative research to further explore its pathophysiological mechanisms, improve early detection, and refine treatment ...

TUESDAY, June 24, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid. The approval is ...

Objective To assess the association between exanthematous diseases, and an earlier age at Type 1 diabetes mellitus diagnosis (T1DM) in a cohort of Brazilian patients. Methods This was a retrospective ...